M. Pasciolla

Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma

J. Leonard, K. van Besien, R. Pearse, 2021, Leukemia & lymphoma.

Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation

D. Salerno, U. Gergis, T. Shore, 2020, Leukemia & lymphoma.

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)

T. Muthukumar, P. Simonson, E. Dicarlo, 2023, Bone Marrow Transplantation.

Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients.

R. Soave, T. Shore, S. Mayer, 2022, Transplantation and cellular therapy.

Efficacy and toxicity of CD19 CAR-T cell therapy for lymphoma in solid organ transplant recipients: a systematic review and meta-analysis.

Zhengming Chen, T. Shore, P. Martin, 2023, Transplantation and cellular therapy.